SEC Form 4 · accession 0001209191-17-064140
MAGELLAN HEALTH INC · MGLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mostafa Kamal
Officer — CEO, Magellan Rx Management
Period of report
Dec 4, 2017
Accepted (ET)
Dec 6, 2017 · 12:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000019411
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Common Stock, $0.01 par value | Dec 4, 2017 | X | 2,180 | $71.00 | A | 2,180 | D | |
| Ordinary Common Stock, $0.01 par value | Dec 4, 2017 | S | 2,180 | $92.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3,F2 | $71.00 | Dec 4, 2017 | X | 2,180 | D | — | Apr 1, 2025 | Common Stock | 2,180 | 1,666 | D |
Explanation of responses
- F1This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
- F2The remainder of 1,666 options shall vest on April 1, 2018.
- F3Not applicable.